This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Older heart failure patients with no immediate family are especially vulnerable. Additional interventions may be necessary to reach these patients and provide the best care possible.
GenAI initiatives are complex and—in some cases—costly. “As such, the main rationale for pursuing them needs to be business growth, not workforce reductions.”
The authors of the survey report note that AI tools mentioned by respondents run the gamut from automated appointment reminders to dynamic “care gap” messaging.
Some AI decision-support models have a proclivity for recommending aggressive care pathways. And doing so on the basis of patient demographics, not medical necessity.
As applications of AI spread rapidly across healthcare, ambient scribes are poised to become one of the fastest technology adoptions in the history of the sector.
The authors of a new commentary in the American Journal of Cardiology argued that well-balanced plant-based diets are good for the heart and good for society as a whole.
Hospitals are still facing tough financial conditions heading into the end of 2022, with the latest National Hospital Flash Report revealing negative margins in October.
This year’s flu season is underway in the United States, and the number of cases is rising, according to the latest flu data from the Centers for Disease Control and Prevention (CDC).
Forbes has announced its annual 30 Under 30 list, highlighting leaders across industries. Within the healthcare space, the list features leaders working to expand access to care and to treat and cure disease.
Carpal tunnel syndrome can be successfully treated without surgery, according to new findings being presented at RSNA 2022 in Chicago. The procedure typically takes just 10 to 15 minutes.
Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.